Cecilia Coccia

Istituti di Ricovero e Cura a Carattere Scientifico

Papers

3

Total Citations

24

H-Index

3

About

Dr. Cecilia Coccia is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for early-stage non-small cell lung cancer (NSCLC), with a particular focus on robotic-assisted lobectomy. Her major contributions include demonstrating the oncological safety and efficacy of robotic lobectomy with radical lymphadenectomy, establishing it as a viable alternative to traditional thoracotomy. In her landmark 2022 study (15 citations), she reported favorable perioperative and oncological outcomes, helping to solidify robotic surgery's role in lung cancer treatment. Dr. Coccia has also addressed the critical question of surgical appropriateness in elderly patients, showing that robotic lobectomy can be safely performed in those over 75 with acceptable perioperative outcomes (6 citations). Her innovative work extends to multimodal pain management, where she evaluated locoregional anaesthesia efficacy after robotic pulmonary lobectomy (3 citations). Through these studies, Dr. Coccia is shaping the future of thoracic oncology by expanding access to minimally invasive surgery for vulnerable populations and refining postoperative care protocols.

Research Focus

Key Achievements

3
H-Index
3
Papers
24
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer
15 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago